In 2023, the FDA deemed 19 peptide drugs too unsafe to be dispensed by compounding pharmacies, which mix components of approved drugs to create bespoke medication for people who have trouble taking Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance[v3] Preprints.org US FDA to convene expert panel to review wider access to some peptides Reuters Statement Of Investigator (FDA Form 1572) When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions FDA's Overreach on Compounded Peptides